nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2E1—liver cancer	0.393	1	CbGaD
Nicardipine—CYP2B6—Sorafenib—liver cancer	0.047	0.156	CbGbCtD
Nicardipine—CYP3A5—Sorafenib—liver cancer	0.037	0.123	CbGbCtD
Nicardipine—CYP2C8—Sorafenib—liver cancer	0.0356	0.118	CbGbCtD
Nicardipine—CYP2C19—Sorafenib—liver cancer	0.0298	0.0991	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—liver cancer	0.0285	0.0947	CbGbCtD
Nicardipine—CYP2C9—Sorafenib—liver cancer	0.0248	0.0824	CbGbCtD
Nicardipine—ABCB1—Sorafenib—liver cancer	0.0241	0.08	CbGbCtD
Nicardipine—CYP2D6—Sorafenib—liver cancer	0.0227	0.0754	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—liver cancer	0.0146	0.0485	CbGbCtD
Nicardipine—CYP3A4—Sorafenib—liver cancer	0.0144	0.0479	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—liver cancer	0.0138	0.0457	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—liver cancer	0.00875	0.0291	CbGbCtD
Nicardipine—Disease progression—Sorafenib—liver cancer	0.00826	0.0865	CcSEcCtD
Nicardipine—Hypophosphataemia—Sorafenib—liver cancer	0.0031	0.0325	CcSEcCtD
Nicardipine—Electrocardiogram ST segment depression—Epirubicin—liver cancer	0.00294	0.0308	CcSEcCtD
Nicardipine—Electrocardiogram ST segment depression—Doxorubicin—liver cancer	0.00272	0.0285	CcSEcCtD
Nicardipine—Oropharyngeal discomfort—Sorafenib—liver cancer	0.00248	0.026	CcSEcCtD
Nicardipine—Nimodipine—AHR—liver cancer	0.00198	0.422	CrCbGaD
Nicardipine—Pericarditis—Epirubicin—liver cancer	0.00154	0.0161	CcSEcCtD
Nicardipine—Pericarditis—Doxorubicin—liver cancer	0.00143	0.0149	CcSEcCtD
Nicardipine—Peripheral vascular disorder—Epirubicin—liver cancer	0.00136	0.0142	CcSEcCtD
Nicardipine—Peripheral vascular disorder—Doxorubicin—liver cancer	0.00126	0.0132	CcSEcCtD
Nicardipine—Hypokalaemia—Sorafenib—liver cancer	0.00119	0.0125	CcSEcCtD
Nicardipine—Hypophosphataemia—Epirubicin—liver cancer	0.00115	0.012	CcSEcCtD
Nicardipine—Hypophosphataemia—Doxorubicin—liver cancer	0.00106	0.0111	CcSEcCtD
Nicardipine—Erectile dysfunction—Sorafenib—liver cancer	0.00104	0.0109	CcSEcCtD
Nicardipine—Acute coronary syndrome—Sorafenib—liver cancer	0.000995	0.0104	CcSEcCtD
Nicardipine—Myocardial infarction—Sorafenib—liver cancer	0.000989	0.0104	CcSEcCtD
Nicardipine—Tinnitus—Sorafenib—liver cancer	0.000845	0.00885	CcSEcCtD
Nicardipine—Flushing—Sorafenib—liver cancer	0.000841	0.00881	CcSEcCtD
Nicardipine—Injection site pain—Epirubicin—liver cancer	0.000816	0.00855	CcSEcCtD
Nicardipine—Vasodilation—Epirubicin—liver cancer	0.000759	0.00795	CcSEcCtD
Nicardipine—Vasodilation procedure—Epirubicin—liver cancer	0.000759	0.00795	CcSEcCtD
Nicardipine—Injection site pain—Doxorubicin—liver cancer	0.000755	0.00791	CcSEcCtD
Nicardipine—Ventricular extrasystoles—Epirubicin—liver cancer	0.000738	0.00773	CcSEcCtD
Nicardipine—Nocturia—Epirubicin—liver cancer	0.000719	0.00753	CcSEcCtD
Nicardipine—Syncope—Sorafenib—liver cancer	0.000707	0.00741	CcSEcCtD
Nicardipine—Vasodilation procedure—Doxorubicin—liver cancer	0.000702	0.00735	CcSEcCtD
Nicardipine—Vasodilation—Doxorubicin—liver cancer	0.000702	0.00735	CcSEcCtD
Nicardipine—Loss of consciousness—Sorafenib—liver cancer	0.000693	0.00726	CcSEcCtD
Nicardipine—Atrioventricular block—Epirubicin—liver cancer	0.000687	0.0072	CcSEcCtD
Nicardipine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.000683	0.00715	CcSEcCtD
Nicardipine—Hypertension—Sorafenib—liver cancer	0.000681	0.00713	CcSEcCtD
Nicardipine—Neck pain—Epirubicin—liver cancer	0.000675	0.00707	CcSEcCtD
Nicardipine—Clevidipine—CYP2E1—liver cancer	0.000672	0.143	CrCbGaD
Nicardipine—Arthralgia—Sorafenib—liver cancer	0.000671	0.00703	CcSEcCtD
Nicardipine—Myalgia—Sorafenib—liver cancer	0.000671	0.00703	CcSEcCtD
Nicardipine—Ventricular tachycardia—Epirubicin—liver cancer	0.000667	0.00698	CcSEcCtD
Nicardipine—Nocturia—Doxorubicin—liver cancer	0.000665	0.00697	CcSEcCtD
Nicardipine—Injection site reaction—Epirubicin—liver cancer	0.000663	0.00694	CcSEcCtD
Nicardipine—Abnormal dreams—Epirubicin—liver cancer	0.000659	0.0069	CcSEcCtD
Nicardipine—Dry mouth—Sorafenib—liver cancer	0.000657	0.00688	CcSEcCtD
Nicardipine—Infection—Sorafenib—liver cancer	0.000639	0.0067	CcSEcCtD
Nicardipine—Atrioventricular block—Doxorubicin—liver cancer	0.000636	0.00666	CcSEcCtD
Nicardipine—Shock—Sorafenib—liver cancer	0.000633	0.00663	CcSEcCtD
Nicardipine—Thrombocytopenia—Sorafenib—liver cancer	0.00063	0.0066	CcSEcCtD
Nicardipine—Neck pain—Doxorubicin—liver cancer	0.000624	0.00654	CcSEcCtD
Nicardipine—Ventricular tachycardia—Doxorubicin—liver cancer	0.000617	0.00646	CcSEcCtD
Nicardipine—Injection site reaction—Doxorubicin—liver cancer	0.000613	0.00642	CcSEcCtD
Nicardipine—Abnormal dreams—Doxorubicin—liver cancer	0.00061	0.00639	CcSEcCtD
Nicardipine—Nilvadipine—CYP2E1—liver cancer	0.000602	0.129	CrCbGaD
Nicardipine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000586	0.00614	CcSEcCtD
Nicardipine—Hypertonia—Epirubicin—liver cancer	0.000584	0.00612	CcSEcCtD
Nicardipine—Abnormal vision—Epirubicin—liver cancer	0.000581	0.00609	CcSEcCtD
Nicardipine—Dyspnoea—Sorafenib—liver cancer	0.000574	0.00601	CcSEcCtD
Nicardipine—Dyspepsia—Sorafenib—liver cancer	0.000566	0.00593	CcSEcCtD
Nicardipine—Constipation—Sorafenib—liver cancer	0.00055	0.00576	CcSEcCtD
Nicardipine—Pain—Sorafenib—liver cancer	0.00055	0.00576	CcSEcCtD
Nicardipine—Hypertonia—Doxorubicin—liver cancer	0.000541	0.00566	CcSEcCtD
Nicardipine—Abnormal vision—Doxorubicin—liver cancer	0.000538	0.00564	CcSEcCtD
Nicardipine—Gastrointestinal pain—Sorafenib—liver cancer	0.000526	0.00551	CcSEcCtD
Nicardipine—Hot flush—Epirubicin—liver cancer	0.000517	0.00542	CcSEcCtD
Nicardipine—Menopausal symptoms—Epirubicin—liver cancer	0.000513	0.00537	CcSEcCtD
Nicardipine—Amlodipine—CYP1A1—liver cancer	0.000512	0.109	CrCbGaD
Nicardipine—Abdominal pain—Sorafenib—liver cancer	0.000509	0.00533	CcSEcCtD
Nicardipine—Body temperature increased—Sorafenib—liver cancer	0.000509	0.00533	CcSEcCtD
Nicardipine—Hot flush—Doxorubicin—liver cancer	0.000479	0.00501	CcSEcCtD
Nicardipine—Menopausal symptoms—Doxorubicin—liver cancer	0.000474	0.00497	CcSEcCtD
Nicardipine—Hypersensitivity—Sorafenib—liver cancer	0.000474	0.00497	CcSEcCtD
Nicardipine—Face oedema—Epirubicin—liver cancer	0.000467	0.00489	CcSEcCtD
Nicardipine—Nifedipine—CYP2E1—liver cancer	0.000464	0.099	CrCbGaD
Nicardipine—Asthenia—Sorafenib—liver cancer	0.000462	0.00484	CcSEcCtD
Nicardipine—Nifedipine—CYP1A1—liver cancer	0.000457	0.0976	CrCbGaD
Nicardipine—Orthostatic hypotension—Epirubicin—liver cancer	0.000442	0.00463	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—liver cancer	0.00044	0.00461	CcSEcCtD
Nicardipine—Diarrhoea—Sorafenib—liver cancer	0.00044	0.00461	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—liver cancer	0.000432	0.00453	CcSEcCtD
Nicardipine—Dizziness—Sorafenib—liver cancer	0.000426	0.00446	CcSEcCtD
Nicardipine—Vomiting—Sorafenib—liver cancer	0.000409	0.00429	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000409	0.00428	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—liver cancer	0.000407	0.00427	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—liver cancer	0.000407	0.00427	CcSEcCtD
Nicardipine—Rash—Sorafenib—liver cancer	0.000406	0.00425	CcSEcCtD
Nicardipine—Dermatitis—Sorafenib—liver cancer	0.000405	0.00425	CcSEcCtD
Nicardipine—Headache—Sorafenib—liver cancer	0.000403	0.00422	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—liver cancer	0.000386	0.00405	CcSEcCtD
Nicardipine—Nausea—Sorafenib—liver cancer	0.000382	0.004	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—liver cancer	0.000377	0.00395	CcSEcCtD
Nicardipine—Conjunctivitis—Epirubicin—liver cancer	0.000362	0.0038	CcSEcCtD
Nicardipine—Sweating—Epirubicin—liver cancer	0.000357	0.00374	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—liver cancer	0.000357	0.00374	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—liver cancer	0.000356	0.00372	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—liver cancer	0.00035	0.00366	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—liver cancer	0.000336	0.00352	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—liver cancer	0.000335	0.00351	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—liver cancer	0.000333	0.00349	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—liver cancer	0.000331	0.00347	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—liver cancer	0.00033	0.00345	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—liver cancer	0.000329	0.00345	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—liver cancer	0.000324	0.00339	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—liver cancer	0.000323	0.00338	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—liver cancer	0.000312	0.00327	CcSEcCtD
Nicardipine—Flushing—Epirubicin—liver cancer	0.000311	0.00325	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—liver cancer	0.000311	0.00325	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—liver cancer	0.000308	0.00323	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—liver cancer	0.000305	0.0032	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—liver cancer	0.000298	0.00313	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—liver cancer	0.000289	0.00303	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—liver cancer	0.000287	0.00301	CcSEcCtD
Nicardipine—Tension—Epirubicin—liver cancer	0.000286	0.003	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—liver cancer	0.000283	0.00296	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—liver cancer	0.000275	0.00288	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—liver cancer	0.00027	0.00283	CcSEcCtD
Nicardipine—Agitation—Epirubicin—liver cancer	0.000268	0.00281	CcSEcCtD
Nicardipine—Tension—Doxorubicin—liver cancer	0.000265	0.00277	CcSEcCtD
Nicardipine—Malaise—Epirubicin—liver cancer	0.000263	0.00275	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—liver cancer	0.000262	0.00274	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—liver cancer	0.000262	0.00274	CcSEcCtD
Nicardipine—Syncope—Epirubicin—liver cancer	0.000261	0.00274	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—liver cancer	0.000258	0.0027	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—liver cancer	0.000256	0.00268	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—liver cancer	0.000254	0.00266	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—liver cancer	0.000252	0.00264	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—liver cancer	0.00025	0.00262	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—liver cancer	0.000248	0.0026	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—liver cancer	0.000248	0.0026	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—liver cancer	0.000248	0.0026	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—liver cancer	0.000248	0.0026	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—liver cancer	0.000247	0.00259	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—liver cancer	0.000245	0.00257	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—liver cancer	0.000243	0.00255	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—liver cancer	0.000243	0.00254	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—liver cancer	0.000242	0.00254	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—liver cancer	0.000242	0.00253	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—liver cancer	0.00024	0.00251	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—liver cancer	0.000238	0.0025	CcSEcCtD
Nicardipine—Oedema—Epirubicin—liver cancer	0.000238	0.00249	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—liver cancer	0.000237	0.00248	CcSEcCtD
Nicardipine—Infection—Epirubicin—liver cancer	0.000236	0.00248	CcSEcCtD
Nicardipine—Shock—Epirubicin—liver cancer	0.000234	0.00245	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—liver cancer	0.000233	0.00244	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—liver cancer	0.000233	0.00244	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—liver cancer	0.000232	0.00243	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—liver cancer	0.00023	0.00241	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—liver cancer	0.00023	0.0024	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—liver cancer	0.00023	0.0024	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—liver cancer	0.00023	0.0024	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—liver cancer	0.000229	0.0024	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—liver cancer	0.000227	0.00238	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—liver cancer	0.000225	0.00235	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—liver cancer	0.000222	0.00233	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—liver cancer	0.000222	0.00232	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—liver cancer	0.00022	0.00231	CcSEcCtD
Nicardipine—Infection—Doxorubicin—liver cancer	0.000219	0.00229	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000217	0.00227	CcSEcCtD
Nicardipine—Shock—Doxorubicin—liver cancer	0.000217	0.00227	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—liver cancer	0.000215	0.00226	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—liver cancer	0.000215	0.00225	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—liver cancer	0.000215	0.00225	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—liver cancer	0.000214	0.00224	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—liver cancer	0.000213	0.00223	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—liver cancer	0.000212	0.00222	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—liver cancer	0.000211	0.00221	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—liver cancer	0.000209	0.00219	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—liver cancer	0.000206	0.00215	CcSEcCtD
Nicardipine—Pain—Epirubicin—liver cancer	0.000203	0.00213	CcSEcCtD
Nicardipine—Constipation—Epirubicin—liver cancer	0.000203	0.00213	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.0002	0.0021	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—liver cancer	0.000199	0.00208	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—liver cancer	0.000198	0.00207	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—liver cancer	0.000196	0.00206	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—liver cancer	0.000196	0.00205	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—liver cancer	0.000196	0.00205	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—liver cancer	0.000194	0.00204	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—liver cancer	0.000194	0.00203	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—liver cancer	0.000188	0.00197	CcSEcCtD
Nicardipine—Pain—Doxorubicin—liver cancer	0.000188	0.00197	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—liver cancer	0.000188	0.00197	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—liver cancer	0.000188	0.00197	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—liver cancer	0.000181	0.0019	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00018	0.00189	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—liver cancer	0.000175	0.00184	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—liver cancer	0.000174	0.00182	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—liver cancer	0.000174	0.00182	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—liver cancer	0.000171	0.00179	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—liver cancer	0.000163	0.0017	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—liver cancer	0.000162	0.0017	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—liver cancer	0.000158	0.00165	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—liver cancer	0.000157	0.00165	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—liver cancer	0.000151	0.00158	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—liver cancer	0.000151	0.00158	CcSEcCtD
Nicardipine—Rash—Epirubicin—liver cancer	0.00015	0.00157	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—liver cancer	0.00015	0.00157	CcSEcCtD
Nicardipine—Headache—Epirubicin—liver cancer	0.000149	0.00156	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—liver cancer	0.000146	0.00152	CcSEcCtD
Nicardipine—Nausea—Epirubicin—liver cancer	0.000141	0.00148	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—liver cancer	0.00014	0.00147	CcSEcCtD
Nicardipine—Rash—Doxorubicin—liver cancer	0.000139	0.00145	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—liver cancer	0.000139	0.00145	CcSEcCtD
Nicardipine—Headache—Doxorubicin—liver cancer	0.000138	0.00144	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—liver cancer	0.000131	0.00137	CcSEcCtD
Nicardipine—ADRA1D—Signaling Pathways—KRAS—liver cancer	4.04e-06	1.96e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCND1—liver cancer	4.03e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CTNNB1—liver cancer	4.03e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—JUN—liver cancer	4.02e-06	1.95e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCND1—liver cancer	4.02e-06	1.95e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—JUN—liver cancer	4.01e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—HMOX1—liver cancer	4.01e-06	1.94e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ALB—liver cancer	4e-06	1.94e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	3.99e-06	1.94e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—liver cancer	3.99e-06	1.93e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	3.98e-06	1.93e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—liver cancer	3.96e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CB—liver cancer	3.96e-06	1.92e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CD—liver cancer	3.95e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—liver cancer	3.95e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CDKN1A—liver cancer	3.95e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—PIK3CA—liver cancer	3.95e-06	1.91e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—liver cancer	3.94e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CDKN1A—liver cancer	3.93e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—PIK3CA—liver cancer	3.92e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—liver cancer	3.91e-06	1.9e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—ALB—liver cancer	3.9e-06	1.89e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KRAS—liver cancer	3.9e-06	1.89e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STAT3—liver cancer	3.9e-06	1.89e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—liver cancer	3.9e-06	1.89e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—liver cancer	3.9e-06	1.89e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	3.9e-06	1.89e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RAF1—liver cancer	3.9e-06	1.89e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—liver cancer	3.89e-06	1.89e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	3.88e-06	1.89e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK8—liver cancer	3.85e-06	1.87e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—liver cancer	3.84e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK8—liver cancer	3.84e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—liver cancer	3.83e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—liver cancer	3.82e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—liver cancer	3.81e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MTOR—liver cancer	3.8e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CB—liver cancer	3.8e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK8—liver cancer	3.8e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PIK3CA—liver cancer	3.8e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PIK3CA—liver cancer	3.8e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—liver cancer	3.79e-06	1.84e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK8—liver cancer	3.79e-06	1.84e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—liver cancer	3.78e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—liver cancer	3.78e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—liver cancer	3.78e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—liver cancer	3.77e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—liver cancer	3.77e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RAF1—liver cancer	3.77e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RAF1—liver cancer	3.77e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—liver cancer	3.76e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—liver cancer	3.76e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—liver cancer	3.73e-06	1.81e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—liver cancer	3.73e-06	1.81e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	3.71e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—liver cancer	3.69e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MTOR—liver cancer	3.68e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—liver cancer	3.68e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—liver cancer	3.68e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MTOR—liver cancer	3.68e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—liver cancer	3.68e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—liver cancer	3.65e-06	1.77e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—liver cancer	3.65e-06	1.77e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—liver cancer	3.65e-06	1.77e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—liver cancer	3.63e-06	1.76e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—liver cancer	3.63e-06	1.76e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—liver cancer	3.62e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—liver cancer	3.6e-06	1.75e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—liver cancer	3.59e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—liver cancer	3.59e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1B—liver cancer	3.57e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—liver cancer	3.56e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—liver cancer	3.55e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.54e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—liver cancer	3.53e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—liver cancer	3.52e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—liver cancer	3.51e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—liver cancer	3.51e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—liver cancer	3.51e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—liver cancer	3.51e-06	1.7e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—liver cancer	3.5e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—liver cancer	3.5e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—liver cancer	3.49e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—liver cancer	3.49e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—liver cancer	3.49e-06	1.69e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—liver cancer	3.49e-06	1.69e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—liver cancer	3.48e-06	1.69e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—liver cancer	3.47e-06	1.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—liver cancer	3.47e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—liver cancer	3.47e-06	1.68e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—liver cancer	3.47e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1B—liver cancer	3.45e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1B—liver cancer	3.45e-06	1.68e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—liver cancer	3.45e-06	1.67e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—liver cancer	3.43e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—liver cancer	3.4e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—JUN—liver cancer	3.4e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—liver cancer	3.38e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—liver cancer	3.38e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—liver cancer	3.38e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—liver cancer	3.38e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—liver cancer	3.37e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—liver cancer	3.37e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—liver cancer	3.36e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—liver cancer	3.36e-06	1.63e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—liver cancer	3.35e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—liver cancer	3.32e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—liver cancer	3.31e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—liver cancer	3.31e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—liver cancer	3.31e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—liver cancer	3.3e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1A—liver cancer	3.29e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—liver cancer	3.29e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—liver cancer	3.29e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—JUN—liver cancer	3.29e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—JUN—liver cancer	3.29e-06	1.6e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—liver cancer	3.28e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—liver cancer	3.27e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—liver cancer	3.26e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—liver cancer	3.26e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—liver cancer	3.26e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—liver cancer	3.26e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—liver cancer	3.25e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—liver cancer	3.25e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARA—liver cancer	3.24e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—liver cancer	3.23e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—liver cancer	3.22e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—liver cancer	3.22e-06	1.56e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—liver cancer	3.22e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—liver cancer	3.22e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK8—liver cancer	3.21e-06	1.56e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—liver cancer	3.21e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—liver cancer	3.21e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—liver cancer	3.21e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—liver cancer	3.21e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—liver cancer	3.2e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—liver cancer	3.2e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—liver cancer	3.2e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—liver cancer	3.2e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1A—liver cancer	3.19e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1A—liver cancer	3.19e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—liver cancer	3.18e-06	1.54e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK8—liver cancer	3.11e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK8—liver cancer	3.11e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—liver cancer	3.1e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—liver cancer	3.1e-06	1.51e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	3.08e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—liver cancer	3.07e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—liver cancer	3.07e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—liver cancer	3.06e-06	1.49e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—liver cancer	3.03e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—liver cancer	3.02e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—liver cancer	3.01e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—liver cancer	2.98e-06	1.45e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—liver cancer	2.98e-06	1.45e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—liver cancer	2.98e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—liver cancer	2.97e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—liver cancer	2.96e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—liver cancer	2.96e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—liver cancer	2.94e-06	1.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—liver cancer	2.93e-06	1.42e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—liver cancer	2.93e-06	1.42e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—liver cancer	2.87e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—liver cancer	2.87e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—liver cancer	2.85e-06	1.38e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—liver cancer	2.85e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—liver cancer	2.84e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—liver cancer	2.84e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—liver cancer	2.84e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—liver cancer	2.84e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—liver cancer	2.83e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—liver cancer	2.83e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—liver cancer	2.79e-06	1.35e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—liver cancer	2.78e-06	1.35e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—liver cancer	2.78e-06	1.35e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—liver cancer	2.77e-06	1.35e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.77e-06	1.35e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—liver cancer	2.77e-06	1.34e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	2.74e-06	1.33e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	2.73e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—liver cancer	2.73e-06	1.33e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—liver cancer	2.73e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—liver cancer	2.72e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—liver cancer	2.71e-06	1.31e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—liver cancer	2.7e-06	1.31e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—liver cancer	2.69e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—liver cancer	2.68e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—liver cancer	2.68e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—liver cancer	2.68e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—liver cancer	2.67e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—liver cancer	2.65e-06	1.29e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—liver cancer	2.65e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—liver cancer	2.64e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—liver cancer	2.64e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—liver cancer	2.64e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—liver cancer	2.64e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—liver cancer	2.62e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—liver cancer	2.62e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—liver cancer	2.57e-06	1.25e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—liver cancer	2.56e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—liver cancer	2.54e-06	1.23e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—liver cancer	2.53e-06	1.23e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—liver cancer	2.52e-06	1.22e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—liver cancer	2.51e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—liver cancer	2.46e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—liver cancer	2.45e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—liver cancer	2.44e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—liver cancer	2.44e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.44e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—liver cancer	2.43e-06	1.18e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—liver cancer	2.42e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—liver cancer	2.41e-06	1.17e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—liver cancer	2.41e-06	1.17e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—liver cancer	2.33e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—liver cancer	2.32e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—liver cancer	2.28e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—liver cancer	2.27e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—liver cancer	2.27e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—liver cancer	2.26e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—liver cancer	2.26e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—liver cancer	2.24e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—liver cancer	2.24e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—liver cancer	2.24e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—liver cancer	2.24e-06	1.09e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—liver cancer	2.23e-06	1.08e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—liver cancer	2.19e-06	1.06e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—liver cancer	2.19e-06	1.06e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—liver cancer	2.17e-06	1.05e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—liver cancer	2.17e-06	1.05e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—liver cancer	2.15e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—liver cancer	2.14e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.12e-06	1.03e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—liver cancer	2.1e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—liver cancer	2.07e-06	1.01e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—liver cancer	2.07e-06	1.01e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—liver cancer	2.05e-06	9.96e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—liver cancer	1.99e-06	9.64e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—liver cancer	1.99e-06	9.64e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.98e-06	9.61e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—liver cancer	1.97e-06	9.56e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.96e-06	9.53e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—liver cancer	1.89e-06	9.19e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—liver cancer	1.83e-06	8.89e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—liver cancer	1.83e-06	8.89e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—liver cancer	1.76e-06	8.54e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—liver cancer	1.72e-06	8.33e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—liver cancer	1.62e-06	7.85e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—liver cancer	1.6e-06	7.78e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.29e-06	6.28e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—liver cancer	1.06e-06	5.13e-06	CbGpPWpGaD
